Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028885 · ClinicalTrials.gov registry record · Phase 1
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate
A Phase 1 study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01028885 is a Phase 1 study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 10 participants.
The verdict
NCT01028885, a Phase 1 study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a prospective clinical trial examining the use of MRI to measure internal organ motion and any resulting changes in the target volume (shape and location) during a course of post-operative radiation therapy for prostate cancer. The goal is to better understand and characterize these physiologic variations so that they can be accounted for during the treatment planning process. The ultimate longer-term clinical goal here is to provide a form of adaptive radiation therapy in the future, such that if major changes are seen over an 8-week course of radiation therapy in our study. This may argue for hypofractionating those patients who are most likely to have major shifts over time.
Interventions
- PROCEDURE computed tomography
- PROCEDURE magnetic resonance imaging
- PROCEDURE intensity-modulated radiation therapy
- PROCEDURE radiation therapy treatment planning/simulation
- PROCEDURE image-guided radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-06 |
| Est. Completion | 2018-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01028885
The ClinicalTrials.gov registry entry for NCT01028885 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which computed tomography is the first listed.
NCT01028885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01028885 about?
NCT01028885 is a clinical study titled "MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate". This is a prospective clinical trial examining the use of MRI to measure internal organ motion and any resulting changes in the target volume (shape and location) during a course of post-operative radiation therapy for prostate cancer. The goal is to better understand and characterize these physiolo...
What is the current status of trial NCT01028885?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2009-06. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01028885?
The interventions under investigation include: computed tomography (PROCEDURE), magnetic resonance imaging (PROCEDURE), intensity-modulated radiation therapy (PROCEDURE), radiation therapy treatment planning/simulation (PROCEDURE), image-guided radiation therapy (PROCEDURE).
Who is sponsoring clinical trial NCT01028885?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.